Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease. Read more about Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease.
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase. Read more about Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex. Read more about The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.
Targeting human SET1/MLL family of proteins. Read more about Targeting human SET1/MLL family of proteins.
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitor. Read more about Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitor.
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2. Read more about Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.
Establishing a reliable framework for harnessing the creative power of the scientific crowd. Read more about Establishing a reliable framework for harnessing the creative power of the scientific crowd.
Peptide recognition by HP1 chromoshadow domains revisited: plasticity in the pseudosymmetric histone binding site of human HP1. Read more about Peptide recognition by HP1 chromoshadow domains revisited: plasticity in the pseudosymmetric histone binding site of human HP1.
Antibody Validation by Immunoprecipitation Followed by Mass Spectrometry Analysis. Read more about Antibody Validation by Immunoprecipitation Followed by Mass Spectrometry Analysis.
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells. Read more about Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
